argenx SE (ARGX) stock
ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$941.25−6.27 (-0.66%)
Close on Nov 18, 2026Market cap –P/E 48.1Yield –
argenx gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2023 it was -$82.30M.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$82.30M | – |
| FY2022 | Dec 31, 2022 | -$19.41M | – |
See a number that looks wrong?